Replies to post #179372 on Vivos Inc (RDGL)

[familyof5]

Hey what can I say. You can't just make this stuff up.....🤑Odds of approval are better than ever before once IDE application is resubmitted.....and the self imposed 45 day window to resubmit is closing quickly.....



From July 29th PRESS RELEASE
https://www.otcmarkets.com/stock/RDGL/news/story?e&id=2930563

Based on our current discussions with the FDA, this week we should receive follow-up questions to fully analyze the risk/benefit device assessment of Radiogel®. We are confident that thus far our submissions have provided 90-95% percent of the information they require and that Vivos will be able to resubmit the refined IDE application with high quality responses demonstrating a compelling risk/benefit analysis to the FDA within the next 45 days.

Dr. Korenko has had plenty of opportunity to revise his self imposed projection but so far so good appears we are still on track.....